According to recent publications, mediating RhoA associated biological processes, ARHGEF3 has been confirmed to interact with IDH (Okada et al., 2003; Kloth et al., 2005) and has unique methylation status in glioma (Northcott et al., 2009). The gene discussed is IDH2; the disease is central nervous system cancer.